Research ArticleClinical Studies
Impact of Stereotactic Radiosurgery Dose on Control of Cerebral Metastases from Renal Cell Carcinoma
DIRK RADES, STEFAN HUTTENLOCHER, NIKLAS GEBAUER, DAGMAR HORNUNG, NGO THUY TRANG, MAI TRONG KHOA and STEVEN E. SCHILD
Anticancer Research June 2015, 35 (6) 3571-3574;
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEFAN HUTTENLOCHER
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
NIKLAS GEBAUER
2Department of Medical Oncology, University of Lübeck, Lübeck, Germany
DAGMAR HORNUNG
3Department of Radiation Oncology, University Medical Center Eppendorf, Hamburg, Germany
NGO THUY TRANG
4Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
MAI TRONG KHOA
4Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
STEVEN E. SCHILD
5Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
In this issue
Impact of Stereotactic Radiosurgery Dose on Control of Cerebral Metastases from Renal Cell Carcinoma
DIRK RADES, STEFAN HUTTENLOCHER, NIKLAS GEBAUER, DAGMAR HORNUNG, NGO THUY TRANG, MAI TRONG KHOA, STEVEN E. SCHILD
Anticancer Research Jun 2015, 35 (6) 3571-3574;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer
- A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder
- Estimating the Survival of Elderly Patients with Renal Cell Carcinoma Presenting with Malignant Spinal Cord Compression